Ind Swift Labs + Glenmark Pharma receive MHRA (UK) approval

Ind Swift Labs has received the MHRA (UK) approval for its 100% export oriented global business unit located at village Jawaharpur, Punjab.

Glenmark Pharmaceuticals has also received approval from MHRA of UK for its state of the art semi-solids (ointments & creams) manufacturing plant at Baddi, Himachal Pradesh. This is the 3rd of the company’s manufacturing plants to have been approved for GMP by the UK regulatory agency – MHRA. This will enable the company’s foray into supply of creams and ointments in Europe soon. The Baddi plant had already received GMP approval from TPD, Canada, and is well on course to receiving USFDA approval in the near future, which would enable the company to enter the niche segment of semi-solid dosages in most of the regulated markets of the world.